Association between angiographically assessed coronary artery disease and serum levels of prostate specific antigen

Clinical Laboratory

Volumn 57, Issue 11-12, 2011, Pages 975-981

  Ali Boroumand, Mohammad ^a   Anvari, Maryam Sotoudeh ^a   Amelimojarad, Elham ^a   Shoar, Saeed ^a   Naderan, Mohammad ^a   Yazdanifard, Parin ^a   Karimi, Abbasali ^a   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary angiography; Coronary artery disease; Gensini score; Prostate specific antigen

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; EPICARDIUM MAPPING; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SMOKING;

ADULT; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; IRAN; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 83455244434     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Patane S, Marte F. Prostate-specific antigen kallikrein: From prostate cancer to cardiovascular system. Eur Heart J 2009;30:1169-70.
2. Koller-Strametz J, Fritzer M, Gwechenberger M, et al. Elevation of prostate-specific markers after cardiopulmonary resuscitation. Circulation 2000;102:290-3. (Pubitemid 30457578)
3. Berent R, Auer J, Porodko M, et al. Influence of cardiopulmonary resuscitation on levels of tumour markers. Eur J Cancer Care (Engl) 2006;15:252-6. (Pubitemid 44050696)
4. Mahfouz RA, Cortas NK, Ibrahim G, Khalife S, Daher RT. Variations in prostate-specific antigen free/total ratio in acute stress. Scand J Clin Lab Invest 2008;68:624-7.
5. Hagood PG, Parra RO, Rauscher JA. Nontraumatic elevation of prostate specific antigen following cardiac surgery and extracorporeal cardiopulmonary bypass. J Urol 1994;152:2043-5. (Pubitemid 24354723)
6. Parlaktas BS, Naseri E, Uluocak N, Elalmis AO, Erdemir F, Etikan I. Comparison of the effects of on-pump versus off-pump coronary artery bypass surgery on serum prostate-specific antigen levels. Int J Urol 2006;13:234-7.
7. Koreny M, Koller-Strametz J, Geppert A, et al. Elevation of prostatic markers following cardiogenic shock. Intensive Care Med 2001;27:447. (Pubitemid 32249994)
8. Ozcan T, Bozlu M, Muslu N, Gozukara KH, Seyis S, Akcay B. Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease. Swiss Med Wkly 2009;139:672-5.
9. Crook M, Preston K, Lancaster I. Serum prostatic specific-antigen concentrations in acute myocardial infarction. Clin Chem 1997;43:1670.
10. Patane S, Marte F, Di Bella G, Ciccarello G. Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2009;137:e37-40.
11. Patane S, Marte F, Di Bella G, Ciccarello G. Changing axis deviation and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2009; 135:e4-5.
12. Patane S, Marte F. Prostate-specific antigen and acute myocardial infarction: A possible new intriguing scenario. Int J Cardiol 2009;134:e147-149.
13. Patane S, Marte F, Sturiale M, Dattilo G. St-segment elevation and diminution of prostate-specific antigen in a patient with coronary spasm and without significant coronary stenoses. Int J Cardiol 2011;148: e31-3.
14. Presti JC, et al. (2008). Benign prostatic hyperplasia (BPH) section of neoplasms of the prostate gland. In EA Tanagho, JW Mcaninch, eds., Smith's General Urology, 17th ed., pp. 348-370. New York: McGraw-Hill.
15. Mener DJ, Cambio A, Stoddard DG, Martin BA, Palapattu GS. The impact of HMG-CoA reductase therapy on serum P)SA. Prostate 2010;70:608-15.
16. Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ. The influence of statin medications on prostate-specific antigen levels. J Natl Cancer Inst 2008,100:1511-8.
17. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. (Pubitemid 13187192)
18. Boroumand MA, Rekabi V, Davoodi G, et al. Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score. Clin Biochem 2008;41:117-20. (Pubitemid 351173038)
19. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): Two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 1998;35:275-368. (Pubitemid 28458755)
20. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL. Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39:2483-91. (Pubitemid 24008233)
21. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
22. Yu H, Diamandis EP. Prostate-specific antigen in milk of lactating women. Clin Chem 1995;41:54-8.
23. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP. Immunoreactive prostate-specific antigen in lung tumors. J Clin Lab Anal 1995;9:375-9.
24. Giai M, Yu H, Roagna R, et al. Prostate-specific antigen in serum of women with breast cancer. Br J Cancer 1995;72:728-31.
25. Wiwanitkit V. Effect of thrombin tube on PSA determination, a clue for false negative in screening for prostate cancer. J Thromb Thrombolysis 2009;27:223-6.
26. Takayama TK, Fujikawa K, Davie EW. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J Biol Chem 1997;272:21582-8. (Pubitemid 27374034)
27. Yoshida E, Ohmura S, Sugiki M, Maruyama M, Mihara H. Prostate-specific antigen activates single-chain urokinase-type plasminogen activator. Int J Cancer 1995;63:863-5.
28. Nielsen JD, Gram J, Holm-Nielsen A, Jespersen J. Bleeding and activation of coagulation during and after transurethral prostatectomy: Importance of the acute-phase response and prostate specific antigen? BJU Int 1999;83:990-5. (Pubitemid 29271865)
29. Braun KP, May M, Helke C, Hoschke B, Ernst H. Endoscopic therapy of a massive rectal bleeding after prostate biopsy. Int Urol Nephrol 2007;39:1125-9. (Pubitemid 350193605)
30. Harris MA, Chadwick D, Ward DC. A novel way of controlling rectal bleeding after transrectal ultrasonography-guided prostate biopsies. BJU Int 2004;93:1358. (Pubitemid 38823969)
31. Lind SE, Caprini JA, Goldshteyn S, Dohnal JC, Vesely SK, Shevrin DH. Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost 2003;89:185-9. (Pubitemid 36149808)
32. Patane S, Marte F, Sturiale M, Grassi R, Patane F. Significant coronary artery disease associated with coronary artery aneurysm and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol; 141:e39-42.
33. Patane S, Marte F. Prostate-specific antigen kallikrein and acute myocardial infarction: Where we are. Where are we going? Int J Cardiol EPub 2009.
34. Sharma JN. The kallikrein-kinin system: From mediator of inflammation to modulator of cardioprotection. Inflammopharmacology 2005;12:591-6. (Pubitemid 41607359)
35. Sharma JN. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system. Arch Med Res 2006;37:299-306.
36. Charlesworth MC, Young CY, Miller VM, Tindall DJ. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. J Androl 1999;20:220-9. (Pubitemid 29203352)
37. Graves HC. Nonprostatic sources of prostate-specific antigen: A steroid hormone-dependent phenomenon? Clin Chem 1995;41:7-9.
38. Weisman KM, Urijani GE, Goldstein MR, Goldberg ME. Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men. Pharmacotherapy 2000;20:383-6. (Pubitemid 30198842)
39. Hahn RG, Farahmand BY, Hallin A, Hammar N, Persson PG. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 2000;55:236-40. (Pubitemid 30069923)
40. Lippi G, Montagnana M, Guidi GC. Epidemiological association between C-reactive protein and prostate-specific antigen. Cancer 2009;115:1132.